The Onco-Genomic Alterations Existing in Cancer Genotypes
Received Date: Apr 18, 2023 / Published Date: May 18, 2023
Abstract
Furthermore, Immunohistochemistry is often being used to validate findings from alternative proteomic studies. For example the validation of prognostic and predictive protein biomarker candidates derived from cell line experiments is commonly performed in clinical tumour samples.
Keywords: Standardization; Immunohistochemistry; Signalling proteins; Antibody-microarray; Expression patterns; Microscopic quantities
Citation: Nai Q (2023) The Onco-Genomic Alterations Existing in Cancer Genotypes. Adv Cancer Prev 7: 162. Doi: 10.4172/2472-0429.1000162
Copyright: © 2023 Nai Q. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Conferences
42nd Global Conference on Nursing Care & Patient Safety
Toronto, CanadaRecommended Journals
Open Access Journals
Article Tools
Article Usage
- Total views: 565
- [From(publication date): 0-2023 - Dec 22, 2024]
- Breakdown by view type
- HTML page views: 451
- PDF downloads: 114
